We have updated our terms and conditions and privacy policy
Click “Continue” to accept and continue with ET HealthWorld
Dear user,
ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.
You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.
If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
After second monkeypox case Centre mandates screening of foreign travellers
India reports second confirmed case of monkeypox from Kerala’s Kannur: Official
Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India
17 July
Adopting-Dynamic-Technologies
The key growth drivers for Eris Lifescience in the next 3-5 years will be an expansion of the power brands franchise, with nine out of our top-15 brands being ranked among the top five among their respective segments
Get exclusive Industry Insights and Analysis through our “Exclusive” Stories brought to you by our award-winning journalists
By continuing, you agree to the Terms & Conditions and acknowledge our Privacy Policy. This same account can be used across all Economic Times B2B portals.
Recommended by Colombia
125000+ Industry Leaders read it everyday
The CBDT on Wednesday accused the makers of the widely-known Dolo-650 medicine tablet of indulging in “unethical practices” and distributing freebies of about Rs 1,000 crore to doctors and medical professionals in exchange for promoting products made by the pharmaceutical group.
The use of antacids, which can cause irregular heartbeats and plaque buildup in the arteries, increases the risk of developing cardiovascular diseases in people with GERD.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.
